Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer

Completed · Phase 2

Conditions studied: Metastatic Breast Cancer

In brief

To determine the therapeutic efficacy of high-dose cyclophosphamide and BCNU with autologous bone marrow transplantation after initial tumor cytoreduction for patients with receptor-negative metastatic breast carcinoma and to determine the optimal timing of CyBCNU-ABMT after initial development of metastatic breast carcinoma

Key facts

Study ID

NCT00584766

Run by

University of Oklahoma

People needed

21

Starts

1987-10-01

Expected to finish

2002-05-01

Last updated by the study team

2015-05-29

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• breast carcinoma at first clinical evidence of metastatic disease
• must have measurable disease by physical exam, x-ray, or scan
• Age < or equal to 55
• performance status 0-2

You may not qualify if…

• can't have had more than one prior chemotherapy regimen
• can't have had concurrent hormonal therapy
• no brain metastases
• no previous pelvic radiation
• no history of another malignancy

Where it is running

• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.